POINT Biopharma Global Inc.
POINT Biopharma Global Inc. (PNT) Revenue
Annual & quarterly revenue history · segment & region breakdown
PNT · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsPOINT Biopharma Global Inc. trailing twelve-month (TTM) revenue is $0.24B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
BiotechnologyCompare PNT revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income POINT Biopharma Global Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
POINT Biopharma Global Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from POINT Biopharma Global Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PNT revenue · 4 questionsPNT's trailing twelve-month (TTM) revenue is $0.24B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · POINT Biopharma Global Inc. SEC filings · GAAP · POINT Biopharma Global Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026